Symberix Co-Founder Gives Keynote Address at AACR Conference

Symberix co-founder Matthew Redinbo gave the keynote address at the AACR Microbiome, Viruses, and Cancer conference on Friday, February 21, 2020. The special conference covers the contribution of bacterial, viral, and fungal pathogens to the development of cancers, as well as the impact of the microbiome on cancer therapy. Dr. Redinbo’s keynote, titled “Molecular control of the gut microbiome to improve cancer chemotherapy”, highlighted the importance of the gut microbiome as a novel drug target to improve the efficacy and tolerability of chemotherapy.